Clinical Research Directory
Browse clinical research sites, groups, and studies.
TAMBE Japan Post-Marketing Surveillance
Sponsor: W.L.Gore & Associates
Summary
To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.
Official title: GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Marketing Surveillance
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2026-03-01
Completion Date
2034-02-28
Last Updated
2026-02-18
Healthy Volunteers
No
Interventions
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
The target patients are those who were attempted to implant the AC during the enrollment period of this surveillance. Patients will also be targeted even if all components of the TAMBE device (devices that can be used in combination with AC specified in IFU) were not used, or if a device other than the component of the TAMBE device was used.
Locations (1)
The Jikei University Hospital
Minatoku, Japan